How I Treat Acute and Persistent Sickle Cell Pain

被引:7
|
作者
Ballas, Samir K. [1 ]
机构
[1] Thomas Jefferson Univ, Cardeza Fdn Hematol Res, Sidney Kimmel Med Coll, Dept Med, Philadelphia, PA 19107 USA
关键词
Sickle cell disease; Sickle cell anemia; Pain; Vaso-occlusive crisis; MAINTENANCE TREATMENT; SELF-MANAGEMENT; DISEASE; MORPHINE; TOLERANCE; LOFEXIDINE; ANEMIA; HYPERALGESIA; FREQUENCY; METHADONE;
D O I
10.4084/MJHID.2020.064
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sickle pain is the hallmark of sickle cell disease (SCD). It could be acute, persistent/relapsing, chronic, or neuropathic. Although there is a general consensus that pain is a major manifestation of SCD, there is a controversy as to the types of pain and their interrelationship between acute, chronic, relapsing, persistent, etc. This report first reviews the general approach to the management of acute vaso-occlusive crisis (VOC) pain, including education, counseling, pharmacotherapy, non-pharmacotherapy, and fluid therapy. This is followed by the presentation of five patients that represent typical issues that are commonly encountered in the management of patients with SCD. These issues are: individualized treatment of pain, bilaterality of pain, use of illicit drugs, tolerance to opioids, opioid-induced hyperalgesia, and withdrawal syndrome. The clinical aspects and management of each of these issues are described. Moreover, such complications as tolerance and withdrawal may persist after discharge and may be mistaken as chronic pain rather than resolving, persistent or relapsing pain.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Mechanisms of pain in sickle cell disease
    Takaoka, Kensuke
    Cyril, Asha Caroline
    Jinesh, Sandhya
    Radhakrishnan, Rajan
    BRITISH JOURNAL OF PAIN, 2021, 15 (02) : 213 - 220
  • [22] AAAPT Diagnostic Criteria for Acute Sickle Cell Disease Pain
    Field, Joshua J.
    Ballas, Samir K.
    Campbell, Claudia M.
    Crosby, Lori E.
    Dampier, Carlton
    Darbari, Deepika S.
    McClish, Donna K.
    Smith, Wally R.
    Zempsky, William T.
    JOURNAL OF PAIN, 2019, 20 (07) : 746 - 759
  • [23] The Risk of Kidney Injury in Patients With Sickle Cell Disease Treated With Ketorolac for Acute Pain
    Harris, Emily M.
    Oni, Morohuntodun O.
    Donado, Carolina
    Heeney, Matthew M.
    Solodiuk, Jean
    Greco, Christine
    Archer, Natasha M.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2024, 46 (05) : e290 - e295
  • [24] Management of Acute Sickle Cell Disease Pain
    Payne, Jason N.
    Gee, Beatrice E.
    PEDIATRICS IN REVIEW, 2024, 45 (01) : 26 - 38
  • [25] Intranasal diamorphine for acute sickle cell pain
    Telfer, P.
    Criddle, J.
    Sandell, J.
    Davies, F.
    Morrison, I.
    Challands, J.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2009, 94 (12) : 979 - 980
  • [26] Thinking beyond sickling to better understand pain in sickle cell disease
    Darbari, Deepika S.
    Ballas, Samir K.
    Clauw, Daniel J.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 93 (02) : 89 - 95
  • [27] Pain site frequency and location in sickle cell disease: The PiSCES project
    McClish, Donna K.
    Smith, Wally R.
    Dahman, Bassam A.
    Levenson, James L.
    Roberts, John D.
    Penberthy, Lynne T.
    Aisiku, Imoigele P.
    Roseff, Susan D.
    Bovbjerg, Viktor E.
    PAIN, 2009, 145 (1-2) : 246 - 251
  • [28] How I Manage Sickle Cell Retinopathy
    Ambrosino, Christina M.
    Scott, Adrienne W.
    CURRENT SURGERY REPORTS, 2024, 12 (10): : 362 - 370
  • [29] Acute and chronic pain management in patients with sickle cell disease in the modern era: a comprehensive review
    Tolu, Seda S.
    Van Doren, Layla
    TRANSFUSION AND APHERESIS SCIENCE, 2022, 61 (05)
  • [30] Review/overview of pain in sickle cell disease
    Ballas, Samir K.
    Darbari, Deepika S.
    COMPLEMENTARY THERAPIES IN MEDICINE, 2020, 49